Arlinda Lee
Stock Analyst at Canaccord Genuity
(1.37)
# 3,446
Out of 4,944 analysts
41
Total ratings
36.59%
Success rate
-0.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arlinda Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $11.11 | +89.02% | 3 | Sep 7, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $600 → $300 | $2.93 | +10,138.91% | 3 | Apr 5, 2022 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $375 → $90 | $25.72 | +249.92% | 5 | Mar 16, 2022 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $45 → $36 | $97.86 | -63.21% | 3 | Mar 7, 2022 | |
| CELC Celcuity | Initiates: Buy | $50 | $52.37 | -4.53% | 1 | Oct 8, 2021 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $151 → $160 | $57.33 | +179.09% | 3 | Aug 16, 2021 | |
| BCYC Bicycle Therapeutics | Maintains: Buy | $36 → $40 | $7.35 | +444.22% | 3 | Jul 15, 2021 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $92 → $105 | $28.97 | +262.44% | 12 | Oct 29, 2020 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $23 → $27 | $65.13 | -58.54% | 3 | May 19, 2020 | |
| BDTX Black Diamond Therapeutics | Initiates: Buy | $50 | $2.77 | +1,705.05% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $4.45 | +5,967.42% | 3 | Nov 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $160 | $0.97 | +16,391.45% | 1 | Mar 29, 2018 |
Delcath Systems
Sep 7, 2023
Maintains: Buy
Price Target: $18 → $21
Current: $11.11
Upside: +89.02%
X4 Pharmaceuticals
Apr 5, 2022
Maintains: Buy
Price Target: $600 → $300
Current: $2.93
Upside: +10,138.91%
Nektar Therapeutics
Mar 16, 2022
Maintains: Buy
Price Target: $375 → $90
Current: $25.72
Upside: +249.92%
Rhythm Pharmaceuticals
Mar 7, 2022
Maintains: Buy
Price Target: $45 → $36
Current: $97.86
Upside: -63.21%
Celcuity
Oct 8, 2021
Initiates: Buy
Price Target: $50
Current: $52.37
Upside: -4.53%
CRISPR Therapeutics AG
Aug 16, 2021
Maintains: Buy
Price Target: $151 → $160
Current: $57.33
Upside: +179.09%
Bicycle Therapeutics
Jul 15, 2021
Maintains: Buy
Price Target: $36 → $40
Current: $7.35
Upside: +444.22%
Ultragenyx Pharmaceutical
Oct 29, 2020
Maintains: Buy
Price Target: $92 → $105
Current: $28.97
Upside: +262.44%
Halozyme Therapeutics
May 19, 2020
Maintains: Buy
Price Target: $23 → $27
Current: $65.13
Upside: -58.54%
Black Diamond Therapeutics
Feb 24, 2020
Initiates: Buy
Price Target: $50
Current: $2.77
Upside: +1,705.05%
Nov 5, 2019
Maintains: Buy
Price Target: $225 → $270
Current: $4.45
Upside: +5,967.42%
Mar 29, 2018
Maintains: Buy
Price Target: $300 → $160
Current: $0.97
Upside: +16,391.45%